Turkey

( DrugBank: Turkey / KEGG DRUG: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
53	Sjogren syndrome	30

53. Sjogren syndrome

Clinical trials : 305 / Drugs : 325 - (DrugBank : 104) / Drug target genes : 58 - Drug target pathways : 188

trials per page:

Showing 1 to 10 of 30 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05644795 (ClinicalTrials.gov)	January 1, 2023	9/11/2022	Wheat-free Diet in the Treatment of Sjogren's Syndrome	Efficacy of a Wheat-free Diet in Autoimmune Diseases: a Pilot Therapeutic Study in Sjogren's Disease ...	Sjogren's Syndrome;Non-celiac Gluten Sensitivity	Dietary Supplement: Wheat/milk free diet (W/MFD) group;Dietary Supplement: Rice/turkeyfree diet (R/T ...	University of Palermo	Aurelio Seidita	Not yet recruiting	18 Years	65 Years	All	30	N/A	Italy
2	NCT05350072 (ClinicalTrials.gov)	July 28, 2022	7/4/2022	Two-arm Study to Assess Efficacy and Safety of Ianalumab (VAY736) in Patients With Active Sjogren's ...	A Randomized, Double-blind, Placebo Controlled, 2-arm Multicenter Phase 3 Study to Assess the Effica ...	Sjogren Syndrome	Biological: VAY736;Other: Placebo	Novartis Pharmaceuticals	NULL	Recruiting	18 Years	N/A	All	285	Phase 3	United States;Austria;Brazil;China;Czechia;France;Germany;Guatemala;Korea, Republic of;Lithuania;Pol ...
3	EUCTR2020-001942-20-SE (EUCTR)	20/04/2022	02/03/2022	Study of safety and tolerability of CFZ533 in patients with Sjögren’s Syndrome	A TWINSS extension trial to evaluate the safety and tolerability of CFZ533 (iscalimab) at two dose l ...	Sjögren syndrome MedDRA version: 21.0;Level: PT;Classification code 10040767;Term: Sjogren's syndrom ...	Product Name: iscalimab Product Code: CFZ533 INN or Proposed INN: ISCALIMAB	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	160	Phase 2	Portugal;United States;Slovenia;Greece;Turkey;Austria;Chile;Israel;Russian Federation;Colombia;Unite ...
4	EUCTR2020-001942-20-NL (EUCTR)	26/10/2021	10/05/2021	Study of safety and tolerability of CFZ533 in patients with Sjögren’s Syndrome	A TWINSS extension trial to evaluate the safety and tolerability of CFZ533 (iscalimab) at two dose l ...	Sjögren syndrome MedDRA version: 21.0;Level: PT;Classification code 10040767;Term: Sjogren's syndrom ...	Product Name: iscalimab Product Code: CFZ533 INN or Proposed INN: ISCALIMAB	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	160	Phase 2	United States;Portugal;Slovenia;Greece;Turkey;Austria;Russian Federation;Chile;Israel;Colombia;Unite ...
5	EUCTR2020-001942-20-IT (EUCTR)	14/04/2021	04/06/2021	Study of safety and tolerability of CFZ533 in patients with Sjögren's Syndrome	A TWINSS extension trial to evaluate the safety and tolerability of CFZ533 (iscalimab) at two dose l ...	Sjögren’s Syndrome. MedDRA version: 21.0;Level: PT;Classification code 10040767;Term: Sjogren's synd ...	Product Name: iscalimab Product Code: [CFZ533] INN or Proposed INN: ISCALIMAB	NOVARTIS PHARMA AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	160	Phase 2	Portugal;United States;Slovenia;Greece;Turkey;Austria;Chile;Israel;Russian Federation;Colombia;Unite ...
6	EUCTR2020-001942-20-PT (EUCTR)	31/03/2021	10/11/2020	Study of safety and tolerability of CFZ533 in patients with Sjögren’s Syndrome	A TWINSS extension trial to evaluate the safety and tolerability of CFZ533 (iscalimab) at two dose l ...	Sjögren syndrome MedDRA version: 21.0;Level: PT;Classification code 10040767;Term: Sjogren's syndrom ...	Product Name: iscalimab Product Code: CFZ533 INN or Proposed INN: ISCALIMAB	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	160	Phase 2	Portugal;United States;Slovenia;Greece;Turkey;Austria;Chile;Israel;Russian Federation;Colombia;Unite ...
7	EUCTR2020-001942-20-DE (EUCTR)	09/02/2021	29/10/2020	Study of safety and tolerability of CFZ533 in patients with Sjögren’s Syndrome	A TWINSS extension trial to evaluate the safety and tolerability of CFZ533 (iscalimab) at two dose l ...	Sjögren syndrome MedDRA version: 21.0;Level: PT;Classification code 10040767;Term: Sjogren's syndrom ...	Product Name: iscalimab Product Code: CFZ533 INN or Proposed INN: ISCALIMAB	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	160	Phase 2	Portugal;United States;Slovenia;Greece;Turkey;Austria;Russian Federation;Chile;Israel;Colombia;Unite ...
8	NCT04541589 (ClinicalTrials.gov)	January 5, 2021	14/8/2020	Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome	A TWINSS Extension Trial to Evaluate the Safety and Tolerability of CFZ533 (Iscalimab) at Two Dose L ...	Sjögren's Syndrome	Drug: CFZ533 (iscalimab);Other: CFZ533 Placebo	Novartis Pharmaceuticals	NULL	Recruiting	18 Years	90 Years	All	214	Phase 2	United States;Argentina;Australia;Austria;Brazil;Canada;Chile;Colombia;France;Germany;Greece;Hungary ...
9	EUCTR2020-001942-20-GR (EUCTR)	04/12/2020	12/10/2020	Study of safety and tolerability of CFZ533 in patients with Sjögren’s Syndrome	A TWINSS extension trial to evaluate the safety and tolerability of CFZ533 (iscalimab) at two dose l ...	Sjögren syndrome MedDRA version: 21.0;Level: PT;Classification code 10040767;Term: Sjogren's syndrom ...	Product Name: iscalimab Product Code: CFZ533 INN or Proposed INN: ISCALIMAB	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	160	Phase 2	United States;Portugal;Slovenia;Greece;Turkey;Austria;Russian Federation;Chile;Israel;Colombia;Unite ...
10	EUCTR2020-001942-20-HU (EUCTR)	16/11/2020	17/09/2020	Study of safety and tolerability of CFZ533 in patients with Sjögren’s Syndrome	A TWINSS extension trial to evaluate the safety and tolerability of CFZ533 (iscalimab) at two dose l ...	Sjögren syndrome MedDRA version: 21.0;Level: PT;Classification code 10040767;Term: Sjogren's syndrom ...	Product Name: iscalimab Product Code: CFZ533 INN or Proposed INN: ISCALIMAB	Novartis Pharma AG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	160	Phase 2	Romania;Australia;Netherlands;Germany;Japan;Sweden;Korea, Republic of;United States;Slovenia;Greece; ...

First Previous1 2 3Next Last